abstract |
The present invention relates to a pharmaceutical composition according to claim 1, comprising a glucopyranosyl-substituted benzene derivative and a DPP IV inhibitor, suitable for the treatment or prevention of one or more selected from the group consisting of type I diabetes, type II diabetes, glucose tolerance Hypoglycemic and hyperglycemic conditions. Additionally, the present invention relates to methods of preventing or treating metabolic disorders and related disorders. |